Publication | Closed Access

Antitumor efficacy and tumor-selective replication with a single intravenous injection of OAS403, an oncolytic adenovirus dependent on two prevalent alterations in human cancer

Tumor-selective ReplicationMedicineImmunologyPathologyAntitumor EfficacyOncolytic Adenovirus DependentImmune Checkpoint InhibitorCancer TreatmentOncologyRadiation OncologyCancer ResearchTumor MicroenvironmentTumor BiologyCancer-associated Virus